rain.png
Sunday June 20th, 2021 3:07PM

Sonoma Pharmaceuticals and Te Arai BioFarma Announce Launch of Two New Microcyn® Technology Products in Australia – Nasocyn® Nasal Care and Oracyn® Oral Care

By The Associated Press

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sep 9, 2020--

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, oral, nasal, and eye care and dermatological conditions, and its New Zealand and Australian partner, Te Arai BioFarma Ltd., today announced the launch of two new products available in Australia. Both of these new products are based on Sonoma’s patented Microcyn ® and Microdacyn ® technology and are available without prescription through pharmacies.

Nasocyn ® Nasal Care clears and cleans blocked nasal passages and sinus cavities and helps stop runny nose while reducing inflammation. Nasocyn Nasal Care is non-irritating and used for preventative and symptomatic care against cold and flu.

Oracyn ® Oral Care spray helps treat infections in the throat and mouth. It is effective against bleeding, irritated and sensitive gums as well as mouth ulcers and sore throats. Oracyn is used as a mouth wash, gargle or rinse and relieves present symptoms while protecting from future infections.

For more information, visit .

“These two new products complement our existing Microcyn product line-up perfectly,” said Scott Lissington, Chief Operating Officer of Te Arai BioFarma. “We are pleased to bring these two new products to the Australian market and increase our presence in the Australasian human patient care and wound healing market.”

Amy Trombly, Chief Executive Officer of Sonoma Pharmaceuticals added, “We are excited to partner with Te Arai BioFarma to develop and launch these promising products in their home market. Nasal and oral care are just two of the many effective treatments available based on our powerful Microcyn® technology. We will continue to work with Te Arai BioFarma and our other worldwide partners to expand the reach of Microcyn® technology around the world.”

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 53 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at . For partnership opportunities, please contact .

Te Arai BioFarma Limited is a privately owned New Zealand and Australian company specializing in medical devices and specialty medicines. We aim to improve health and productivity through the affordable control and prevention of disease. Te Arai BioFarma is committed to maintaining long term collaborative and innovative relationships with significant global suppliers of health products. Through partnering with leading suppliers both locally and internationally, Te Arai BioFarma is committed to guaranteeing the highest standard of care is taken in bringing products from these suppliers to Australasia. More information can be found at .

Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the “company”). These forward-looking statements are identified by the use of words such as “continue,” “launch,” “expand” and “develop,” among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company’s business that could cause actual results to vary, including such risks resulting from the global COVID-19 pandemic, that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company’s patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company’s products will not be as large as expected, the company’s products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company’s cash needs, fund further development and clinical studies, as well as uncertainties relative to varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company’s filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law.

Sonoma Pharmaceuticals™, Microcyn ® and Microdacyn ® are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.

View source version on businesswire.com:

CONTACT: Media and Investor Contact:

Sonoma Pharmaceuticals, Inc.

[email protected]

KEYWORD: AUSTRALIA/OCEANIA AUSTRALIA UNITED STATES NORTH AMERICA GEORGIA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH OTHER HEALTH

SOURCE: Sonoma Pharmaceuticals, Inc.

Copyright Business Wire 2020.

PUB: 09/09/2020 04:10 PM/DISC: 09/09/2020 04:10 PM

http://www.businesswire.com/news/home/20200909005953/en

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Online - Georgia News, AP Business Wire - Georgia, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Explosive wildfires across California stoked by fierce winds
Wildfires are raging unchecked across parts of the western United States as winds sweep the region
4:09PM ( 9 minutes ago )
Book: Trump said of virus, 'I wanted to always play it down'
A new book reveals that President Donald Trump seemed to understand the severity of the coronavirus threat even as he was telling the nation that it was no worse than the seasonal flu and insisting that the U.S. government had it totally under control
4:09PM ( 9 minutes ago )
Human rights groups ask IOC to move Olympics from China
China’s repression in Tibet, the status of the exiled Dali Lama and its treatment of ethnic minorities spurred violent protests ahead of Beijing’s 2008 Olympics
4:05PM ( 13 minutes ago )
Associated Press (AP)
Trump still visiting Nevada despite virus limits on rallies
President Donald Trump is planning to travel to Nevada this weekend, though large airport rallies initially set for Las Vegas and Reno appear to have been scuttled after local officials warned they would violate Nevada’s coronavirus-related ban on gatherings of more than 50 people
3:22PM ( 55 minutes ago )
What slowdown? Amazon seeks to hire 33,000 people
Amazon is on a hiring spree
3:20PM ( 58 minutes ago )
Stocks bounce back on Wall Street as tech bloodletting halts
Wall Street is snapping back on Wednesday from its recent tumble, as the bloodletting for big technology stocks comes to at least a temporary halt
3:17PM ( 1 hour ago )
AP Business
Luxury goods giant LVMH cancels $14.5B deal for Tiffany
Luxury goods giant LVMH is ending its months-long pursuit of jewelry retailer Tiffany & Co. The Paris-based conglomerate said that the French government requested a delay, saying it needs more time to assess the impact of proposed U.S. tariffs
12:55PM ( 3 hours ago )
Fire sweeps refugee camp on Greek island amid virus lockdown
Fire swept through a notoriously overcrowded refugee camp on the Greek island of Lesbos, causing no injuries but leaving thousands in need of emergency shelter
12:39PM ( 3 hours ago )
Jalen Ramsey gets 5-year, $105 million extension from Rams
Jalen Ramsey is becoming the highest-paid defensive back in NFL history after agreeing to a five-year, $105 million contract extension with the Los Angeles Rams
12:06PM ( 4 hours ago )
AP Business - Corporate News
Georgia Tech mum on name of Yellow Jackets' starting QB
Georgia Tech has selected a starting quarterback but aren't publicly saying who the player is before Saturday’s season opener at Florida State
2:01PM ( 2 hours ago )
UPS says it plans to hire more than 100,000 holiday workers
UPS says it plans to hire more than 100,000 extra workers to help handle an increase in packages during the holiday season
10:56AM ( 5 hours ago )
Sánchez, 4 relievers throw 4-hitter as Marlins blank Braves
Sixto Sánchez combined with four relievers on a four-hitter, Jorge Alfaro hit one of three homers for Miami and the Marlins beat the Atlanta Braves 8-0
11:23PM ( 16 hours ago )
AP Online - Georgia News
AP Business Wire - Georgia
UN protection back for threatened Nobel-winning Congo doctor
For weeks, a Nobel Peace Prize-winning Congolese doctor has faced death threats, leading alarmed supporters to urge the United Nations to reinstate the peacekeepers who were withdrawn from his hospital months ago
1:46PM ( 2 hours ago )
Stocks perk up on Wall Street as tech bloodletting halts
Wall Street is steadying itself Wednesday following a three-day losing streak, the first in nearly three months
12:34PM ( 3 hours ago )
Strong start for stocks on Wall Street a day after sell-off
Stocks are off to good start on Wall Street, a day after more steep drops in big technology companies pulled indexes sharply lower
9:42AM ( 6 hours ago )
AP Business - Industries
The Latest: Las Vegas children contract inflammatory disease
Health officials said Tuesday that eight Las Vegas-area children under age 14 who tested positive for COVID-19 since March were also diagnosed with a rare inflammatory condition linked with the coronavirus
4:30PM ( 23 hours ago )
The Latest: Boston testing lab suspended over virus results
State officials in Massachusetts said a Boston-based coronavirus testing lab that counts dozens of nursing homes among its clients has been suspended by the state after it returned nearly 400 false positive tests
3:43PM ( 1 day ago )
The Latest: Oklahoma female prisoner treated for virus dies
A female Oklahoma state prison inmate treated for coronavirus has died, the Oklahoma Department of Corrections said
3:06PM ( 1 day ago )
AP Business - Health Care
Explosive wildfires across California stoked by fierce winds
Wildfires are raging unchecked across parts of the western United States as winds sweep the region
4:09PM ( 9 minutes ago )
Book: Trump said of virus, 'I wanted to always play it down'
A new book reveals that President Donald Trump seemed to understand the severity of the coronavirus threat even as he was telling the nation that it was no worse than the seasonal flu and insisting that the U.S. government had it totally under control
4:09PM ( 9 minutes ago )
Human rights groups ask IOC to move Olympics from China
China’s repression in Tibet, the status of the exiled Dali Lama and its treatment of ethnic minorities spurred violent protests ahead of Beijing’s 2008 Olympics
4:05PM ( 13 minutes ago )
New fire breaks out in crowded refugee camp on Greek island
Fire has again struck Greece’s notoriously overcrowded refugee camp on the island of Lesbos, a day after a blaze swept through the camp and left thousands in need of emergency shelter
4:02PM ( 16 minutes ago )
Mandela's lawyer, anti-apartheid activist George Bizos dies
Anti-apartheid crusader and Nelson Mandela’s personal lawyer George Bizos has died at 92, his family says
3:57PM ( 21 minutes ago )